Model Number BXA075902A |
Device Problem
Obstruction of Flow (2423)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 02/17/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
|
|
Event Description
|
On (b)(6) 2020 a patient underwent aortic aneurysm treatment within the tambe 1701 clinical study.Two gore® viabahn® vbx balloon expandable endoprosthesis were utilized in the superior mesenteric artery (sma).On (b)(6) 2021 sma stenosis was reported.
|
|
Manufacturer Narrative
|
D.10.As it is not known which device was involved, or if both were involved, the following device is also being investigated: bxa075902a sn: (b)(6), udi: (b)(4).
|
|
Event Description
|
On (b)(6) 2020 a patient underwent aortic aneurysm treatment within the tambe 1701 clinical study.Two gore® viabahn® vbx balloon expandable endoprosthesis were utilized in the superior mesenteric artery (sma).On (b)(6) 2020, the mesenteric artery circulation was evaluated with pulse wave doppler and color flow duplex imaging.The sma was found to be patent with normal flow velocities and doppler profile.On (b)(6) 2021 sma stenosis was reported.This was described as hemodynamically significant (>70%).This was treated by means of angioplasty.On (b)(6) 2021 the mesenteric artery circulation was evaluated with pulse wave doppler and color flow duplex imaging.This showed a patent sma with normal flow velocities and doppler profile.
|
|
Manufacturer Narrative
|
H.6.Results code 1: 213: a review of the manufacturing records for the device verified the lot met pre-release specifications.
|
|
Manufacturer Narrative
|
Added pma/510(k)number.
|
|
Search Alerts/Recalls
|